Chemoinformaics analysis of ETHYL (9E,12E)-OCTADECA-9,12-DIENOATE
| Molecular Weight | 308.506 | nRot | 15 |
| Heavy Atom Molecular Weight | 272.218 | nRig | 3 |
| Exact Molecular Weight | 308.272 | nRing | 0 |
| Solubility: LogS | -6.596 | nHRing | 0 |
| Solubility: LogP | 7.217 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 59.0085 |
| nHD | 0 | BPOL | 38.7195 |
| QED | 0.2 |
| Synth | 2.305 |
| Natural Product Likeliness | 0.875 |
| NR-PPAR-gamma | 0.352 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.013 |
| HIA | 0.003 |
| CACO-2 | -4.526 |
| MDCK | 0.0000186 |
| BBB | 0.119 |
| PPB | 0.97294 |
| VDSS | 2.707 |
| FU | 0.0207177 |
| CYP1A2-inh | 0.939 |
| CYP1A2-sub | 0.166 |
| CYP2c19-inh | 0.601 |
| CYP2c19-sub | 0.058 |
| CYP2c9-inh | 0.637 |
| CYP2c9-sub | 0.937 |
| CYP2d6-inh | 0.337 |
| CYP2d6-sub | 0.098 |
| CYP3a4-inh | 0.608 |
| CYP3a4-sub | 0.068 |
| CL | 7.094 |
| T12 | 0.265 |
| hERG | 0.104 |
| Ames | 0.014 |
| ROA | 0.009 |
| SkinSen | 0.976 |
| Carcinogencity | 0.208 |
| EI | 0.974 |
| Respiratory | 0.599 |
| NR-Aromatase | 0.388 |
| Antiviral | No |
| Prediction | 0.526842 |